Sec13 Regulates Expression of Specific Immune Factors Involved in Inflammation In Vivo

The Sec13 protein functions in various intracellular compartments including the nuclear pore complex, COPII-coated vesicles, and inside the nucleus as a transcription regulator. Here we developed a mouse model that expresses low levels of Sec13 (Sec13(H/-)) to assess its functions in vivo, as Sec13 knockout is lethal. These Sec13 mutant mice did not present gross defects in anatomy and physiology. However, the reduced levels of Sec13 in vivo yielded specific immunological defects. In particular, these Sec13 mutant mice showed low levels of MHC I and II expressed by macrophages, low levels of INF-gamma and IL-6 expressed by stimulated T cells, and low frequencies of splenic IFN-gamma+CD8+ T cells. In contrast, the levels of soluble and membrane-bound TGF-beta as well as serum immunoglobulin production are high in these mice. Furthermore, frequencies of CD19+CD5-CD95+and CD19+CD5-IL-4+ B cells were diminished in Sec13(H/-) mice. Upon stimulation or immunization, some of the defects observed in the naive mutant mice were compensated. However, TGF-beta expression remained high suggesting that Sec13 is a negative modulator of TGF-beta expression and of its immunosuppressive functions on certain immune cells. In sum, Sec13 regulates specific expression of immune factors with key functions in inflammation.